- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00366158
EVITA: Evaluation of VIP Feature in Pacemaker Patients
February 1, 2019 updated by: Abbott Medical Devices
The primary efficacy objective of this clinical investigation is to demonstrate that the Ventricular Intrinsic Preference (VIP™) feature allows to reduce the medium- and long-term incidence of unnecessary ventricular pacing in patients with intact AV conduction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
461
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient has an indication for implantation of a dual-chamber pacemaker;
- Patient is implanted or scheduled to be implanted with a St Jude Medical Victory pacemaker, or newer device with the same study relevant feature.
Exclusion Criteria:
- Patient has persistent or permanent AF/AFl;
- Patient has permanent AV Block;
- Patient has a pacemaker replacement;
- Patient is in NYHA class IV;
- Patient is unable to attend the follow-up visits;
- Patient is pregnant;
- Patient is less than 18 years of age
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Ventricular Instrinsic Preference (VIP) turned ON
|
Pacemaker implant
Programming of pacemaker
|
|
Active Comparator: 2
Ventricular Instrinsic Preference (VIP) turned OFF
|
Pacemaker implant
Programming of pacemaker
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percentage of ventricular pacing
Time Frame: 6 and 12 months
|
6 and 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Alexander Bauer, MD, Universitätskliniken Heidelberg, Heidelberg, 69115, Germany
- Principal Investigator: Charles Kennergren, MD, Sahlgrenska University Hospital, Sweden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2006
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
September 1, 2010
Study Registration Dates
First Submitted
August 18, 2006
First Submitted That Met QC Criteria
August 18, 2006
First Posted (Estimate)
August 21, 2006
Study Record Updates
Last Update Posted (Actual)
February 4, 2019
Last Update Submitted That Met QC Criteria
February 1, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR06001LV
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
Boston Scientific CorporationNot yet recruitingAtrial Arrhythmia | Intracardiac EchocardiographyNew Zealand, Malaysia, Greece, Croatia, Singapore, Poland, Czechia, Australia
-
Fayoum University HospitalRecruiting
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Arrhythmia | Heart Failure, Congestive | Sinus Arrhythmia
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationRecruiting
-
University of UtahAltaThera Pharmaceuticals, LLCCompleted
-
Universitätsklinikum KölnUnknown
-
St. Joseph's Centre, PolandCompleted
-
Ceryx Medical AustraliaAvaniaRecruitingHeart Failure With Reduced Ejection FractionAustralia, New Zealand
Clinical Trials on Device: St. Jude Medical Victory dual-chamber pacemaker
-
Abbott Medical DevicesTerminated
-
University of MichiganActive, not recruitingBradycardia | Device Related Infection | Device MalfunctionKenya, Sierra Leone, Venezuela, Nigeria, Paraguay, Mexico, Mozambique
-
Abbott Medical DevicesCompletedAtrial Fibrillation | BradycardiaGermany
-
Haran Burri, MDAbbott Medical DevicesTerminatedBradyarrhythmiaSwitzerland, Netherlands
-
China National Center for Cardiovascular DiseasesChinese Academy of Medical Sciences, Fuwai Hospital; Shanghai Jiaotong University... and other collaboratorsUnknownSick Sinus Syndrome | Permanent Pacemaker Implantation | Cardioneuroablation | Ganglionated PlexusChina
-
Abbott Medical DevicesCompletedHeart FailureChina, United States, Puerto Rico, Argentina, Brazil, Colombia, India, Japan, Korea, Republic of
-
Abbott Medical DevicesCompletedVentricular Fibrillation | Ventricular TachycardiaGermany, Greece
-
Abbott Medical DevicesCompletedHeart FailureGermany
-
Abbott Medical DevicesCompletedHeart Failure | Persistent Atrial Fibrillation | ICDGermany, Hungary, Spain
-
Vanderbilt University Medical CenterAbbott Medical DevicesTerminatedBilateral Vocal Fold Paralysis (BVFP)